您好，欢迎来到国际肝病网！

其他专题：APASL|APASL2014 |APASL2013|APASL2012|APASL2011|APASL2010|APASL2009|国际肝病

壁报展示

专题首页 » 壁报展示

⇔ The Need for a Dynamic Approach to Modelling Disease Progression in Cost-Effectiveness Studies of Antiviral Therapies in Patients with Chronic Hepatitis C 2010-05-13
⇔ On-Treatment Decline in Serum HBsAg Levels Predicts Sustained Immune Control and HBsAg Clearance 6 Months Post-Treatment in HBeAg-Positive Hepatitis B Virus-Infected Patients Treated with Peginterferon Alfa-2a [40KD] (PEGASYS) 2010-05-13
⇔ Long-term Efficacy of Entecavir Therapy on Viral Suppression in Nucleoside-na ve 2010-05-13
⇔ Modelling the impact of treatment with entecavir on long-term mortality，morbidity and healthcare costs of chronic hepatitis B in France 2010-05-13
⇔ TELBIVUDINE ADD-ON THERAPY FOR A CIRRHOTIC PATIENT WITH CHRONIC HEPATITIS B WHO FAILED SEQUENTIAL TREATMENT WITH LAMIVUDINE AND ADEFOVIR: A CASE REPORT 2010-05-13
⇔ Baseline characteristics and interim on-treatment responses from the real-world PROPHESYS cohorts inform future treatment paradigms for chronic hepatitis C(CHC) 2010-05-12

首页 1 尾页

专题标签

学术领域

扫描二维码，用手机看今日话题